Cytokinetics Incorporated Receivables Turnover Ratio (CYTK), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cytokinetics Incorporated  (NASDAQ: CYTK)
 

Cytokinetics Incorporated Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Cytokinetics Incorporated's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 5.47, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Cytokinetics Incorporated in Sep 30 2026 quarter, has decreased to 67 days, compared to 68 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 352 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 917 to 977.

What is Receivable Turnover Ratio?
What is Cytokinetics Incorporated Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CYTK Receivables Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Receivable Change 1774.39 % 190.51 % 239.31 % 6.69 % 640.98 %
Y / Y Revenue Change 2356.46 % -57.13 % 1125.78 % 4.89 % 318.14 %
Receivable Turnover Ratio (TTM) 5.47 5.33 12.16 11.74 12.08
CYTK's Total Ranking # 977 # 917 # 2947 # 917 #
Accounts Receivable average collection period days 67 69 30 31 30
Seq. Receivable Change 38.71 % 257.87 % -61.57 % 882.52 % -78.5 %
Seq. Revenue Change 66.14 % 47.89 % 9.01 % 817.1 % -97.1 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 104
Healthcare Sector # 353
Overall Market # 977

Receivable Turnover Ratio Statistics
High Average Low
72.36 10.64 2.68
(Mar 31 2023)   (Mar 31 2024)





CYTK Company Profile • Back to CYTK Efficiency Comparisons • Compare CYTK Receivables Turnover Ratio to its Competitors

Financial Statements
Cytokinetics Incorporated's Accounts Receivable $ 34 Millions Visit CYTK's Balance sheet
Cytokinetics Incorporated's Sales TTM $ 113 Millions Visit CYTK's Income Statement
Sources of CYTK's Revenues Visit CYTK's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CYTK's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CYTK's Growth Rates CYTK's Roa CYTK's Inventory Turnover Ratio CYTK's Dividend Comparisons
CYTK's Profitability Ratios CYTK's Roi CYTK's Asset Turnover Ratio CYTK's Dividend Growth
CYTK's Valuation Ratios CYTK's Roe CYTK's Financial Strength Ratios CYTK's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Receivable at quarter ending Sep 30 2026
Bausch Health Companies Inc   9.15 $ 11,113.000  Millions$ 1,215.000  Millions
Pacs Group Inc   8.88 $ 5,705.049  Millions$ 642.729  Millions
Axogen inc   8.71 $ 266.926  Millions$ 30.654  Millions
Ensign Group Inc  8.62 $ 5,674.305  Millions$ 658.477  Millions
Pediatrix Medical Group Inc   8.57 $ 1,959.124  Millions$ 228.471  Millions
Tenet Healthcare Corp  8.54 $ 22,154.000  Millions$ 2,593.250  Millions
Brightspring Health Services Inc   8.50 $ 9,479.144  Millions$ 1,114.763  Millions
Sotera Health Company  8.49 $ 1,230.250  Millions$ 144.974  Millions
Tactile Systems Technology Inc   8.23 $ 357.176  Millions$ 43.385  Millions
Penumbra Inc  8.22 $ 1,560.334  Millions$ 189.735  Millions
Inspire Medical Systems inc   8.15 $ 882.194  Millions$ 108.207  Millions
Adapthealth Corp   8.14 $ 3,152.043  Millions$ 387.280  Millions
Rhythm Pharmaceuticals Inc   8.03 $ 280.748  Millions$ 34.950  Millions
Alphatec Holdings Inc   7.91 $ 839.652  Millions$ 106.153  Millions
Exelixis Inc   7.89 $ 2,496.861  Millions$ 316.636  Millions
Henry Schein Inc   7.84 $ 13,734.000  Millions$ 1,752.000  Millions
Idexx Laboratories Inc  7.78 $ 4,663.675  Millions$ 599.701  Millions
Madrigal Pharmaceuticals Inc   7.70 $ 1,427.940  Millions$ 185.380  Millions
Pulmonx Corporation  7.56 $ 89.176  Millions$ 11.791  Millions
Merit Medical Systems Inc  7.53 $ 1,612.236  Millions$ 214.065  Millions
Cerus Corporation  7.48 $ 226.798  Millions$ 30.308  Millions
Insmed Inc  7.45 $ 1,479.040  Millions$ 198.502  Millions
Novocure Limited  7.44 $ 725.388  Millions$ 97.525  Millions
Intuitive Surgical Inc   7.44 $ 12,115.600  Millions$ 1,629.350  Millions
Quest Diagnostics Inc  7.43 $ 11,841.000  Millions$ 1,593.250  Millions
Travere Therapeutics Inc   7.32 $ 651.034  Millions$ 88.900  Millions
Si bone inc   7.19 $ 222.189  Millions$ 30.881  Millions
Aurinia Pharmaceuticals Inc   7.18 $ 321.738  Millions$ 44.795  Millions
Beta Bionics Inc   7.15 $ 127.899  Millions$ 17.897  Millions
Tarsus Pharmaceuticals Inc   7.15 $ 682.203  Millions$ 95.466  Millions

Date modified: 2026-11-05T09:33:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.